Figure 1.
Liquid biopsy platforms and processes that regulate them in cancer. Several processes affect the state of biofluids (right) and their content of liquid biopsy analytes. Each form of liquid biopsy (CTCs, cfDNA, EVs, platelets, and leukocytes) may be affected by unique regulatory influences that may change the content of biological information (see text for details).